News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
446,081 Results
Type
Article (20892)
Company Profile (138)
Press Release (425051)
Section
Business (143306)
Career Advice (904)
Deals (25899)
Drug Delivery (70)
Drug Development (54511)
Employer Resources (75)
FDA (9978)
Job Trends (9380)
News (239553)
Policy (23277)
Tag
Academia (1083)
Alliances (33680)
Alzheimer's disease (671)
Approvals (9995)
Artificial intelligence (94)
Bankruptcy (265)
Best Places to Work (6921)
Breast cancer (99)
Cancer (775)
Career advice (781)
Cell therapy (144)
Clinical research (44311)
Collaboration (320)
Compensation (175)
COVID-19 (1722)
C-suite (107)
Data (892)
Diabetes (111)
Diagnostics (3237)
Earnings (60519)
Employer resources (71)
Events (68177)
Executive appointments (377)
FDA (10463)
Funding (294)
Gene therapy (124)
GLP-1 (400)
Government (3072)
Healthcare (9457)
Infectious disease (1796)
Inflammatory bowel disease (69)
Interviews (111)
IPO (11709)
Job creations (2753)
Job search strategy (711)
Layoffs (239)
Legal (5792)
Lung cancer (100)
Manufacturing (160)
Medical device (6121)
Medtech (6124)
Mergers & acquisitions (14350)
Metabolic disorders (306)
Neuroscience (880)
NextGen: Class of 2025 (3297)
Non-profit (1815)
Northern California (1143)
Obesity (171)
Opinion (140)
Patents (114)
People (41894)
Pharmaceutical (70)
Phase I (12841)
Phase II (19348)
Phase III (15460)
Pipeline (466)
Postmarket research (1806)
Preclinical (5458)
Press Release (72)
Radiopharmaceuticals (164)
Rare diseases (166)
Real estate (3893)
Regulatory (15446)
Research institute (1046)
Resumes & cover letters (125)
Southern California (972)
Startups (2256)
United States (10174)
Vaccines (429)
Weight loss (106)
Date
Today (79)
Last 7 days (236)
Last 30 days (1213)
Last 365 days (21940)
2025 (1079)
2024 (22226)
2023 (25865)
2022 (34690)
2021 (36970)
2020 (35561)
2019 (27071)
2018 (20954)
2017 (21574)
2016 (20449)
2015 (24815)
2014 (20092)
2013 (16845)
2012 (18151)
2011 (19042)
2010 (17776)
Location
Africa (489)
Arizona (102)
Asia (28728)
Australia (4135)
California (2532)
Canada (1099)
China (216)
Colorado (111)
Connecticut (117)
Europe (57613)
Florida (392)
Georgia (75)
Illinois (230)
Indiana (146)
Japan (74)
Maryland (481)
Massachusetts (2071)
Michigan (128)
Minnesota (164)
New Jersey (820)
New York (694)
North Carolina (514)
Northern California (1143)
Ohio (79)
Pennsylvania (581)
South America (732)
Southern California (972)
Texas (354)
Virginia (75)
Washington State (212)
446,081 Results for "protect pharmaceutical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Protect Pharmaceutical Corp. Issues Corporate Update
Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: “July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the fiscal year of 2023 is near completion.
July 1, 2024
·
4 min read
Drug Development
Future-Proofing: Inclusive and Protective Patient Strategies
In this episode, the third and final conversation of our mini-series on diversity in clinical trials, Lori and guests discuss framing strategies designed to protect DEI initiatives from legal challenges.
August 29, 2024
·
1 min read
·
Lori Ellis
Deals
Protect Pharmaceutical Corp. Acquires Bosfor Export
Protect Pharmaceutical Corp. “OTC: PRTT” is pleased to announce the acquisition of Bosfor Export.
November 24, 2023
·
1 min read
Press Releases
Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment
January 20, 2025
·
4 min read
Press Releases
Protect Pharmaceutical Corp. (PRTT) Finalizes the Merger with KARINCA Logistics
August 28, 2024
·
3 min read
Press Releases
InteliChart Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance
January 21, 2025
·
3 min read
Deals
DermTech Files for Voluntary Chapter 11 Protection
DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware.
June 18, 2024
·
5 min read
Press Releases
Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
December 10, 2024
·
4 min read
Press Releases
Leyden Labs Raises $70M to Advance its Intranasal Antibody Programs to Protect against Influenza and other Viruses
January 9, 2025
·
3 min read
Press Releases
Annovis Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection
January 15, 2025
·
3 min read
1 of 44,609
Next
